Usana Health Sciences logo

Usana Health Sciences Share Price (NYSE: USNA)

$31.74

0.36

(1.15%)

Live

Last updated on

Check the interactive Usana Health Sciences Stock chart to analyse performance

Usana Health Sciences Inc. Key Stats

Check Usana Health Sciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$31.38
Open
$31.76
Market Capitalization
$586.7M
Today's Volume
$111.8K
Revenue TTM
$899.2M
EBITDA
$79.9M
Earnings Per Share (EPS)
$1.8
PE Ratio
17.84
Profit Margin
3.79%
Quarterly Earnings Growth YOY
-0.04%
Return On Equity TTM
6.35%

Stock Returns calculator for Usana Health Sciences Stock including INR - Dollar returns

The Usana Health Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Usana Health Sciences investment value today

Current value as on today

₹83,278

Returns

₹16,722

(-16.72%)

Returns from Usana Health Sciences Stock

₹21,900 (-21.9%)

Dollar Returns*

₹5,177 (+5.18%)

Indian investors sentiment towards Usana Health Sciences Stock

-26%

Period: Jul 29, 2025 to Aug 28, 2025. Change in 30 Days versus previous period

Search interest for Usana Health Sciences Stock from India on INDmoney has decreased by -26% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Usana Health Sciences Inc.

  • Name

    Holdings %

  • BlackRock Inc

    10.07%

  • Pzena Investment Management, LLC

    6.00%

  • Renaissance Technologies Corp

    5.94%

  • Vanguard Group Inc

    5.54%

  • Dimensional Fund Advisors, Inc.

    4.92%

  • State Street Corp

    2.47%

Analyst Recommendation on Usana Health Sciences Stock

Rating
Trend

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Usana Health Sciences(by analysts ranked 0 to 5 stars)

Usana Health Sciences Share Price Target

What analysts predicted

Upside of 92.19%

Target:

$61.00

Current:

$31.74

Usana Health Sciences share price target is $61.00, a slight Upside of 92.19% compared to current price of $31.74 as per analysts' prediction.

Usana Health Sciences Stock Insights

  • Price Movement

    In the last 7 days, USNA stock has moved down by -2.6%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 249.53M → 235.84M (in $), with an average decrease of 5.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 4.48M → 9.65M (in $), with an average increase of 27.5% per quarter
  • USNA vs K (1 yr)

    In the last 1 year, Usana Health Sciences Inc. has experienced a drawdown of -22.7%, however Kellanova resisted the overall trend and outperformed by 21.4%
  • USNA vs K (3 yr)

    In the last 3 years, Kellanova has given 7.1% return, outperforming this stock by 59.4%
  • Price to Sales

    ForUSNA every $1 of sales, investors are willing to pay $0.7, whereas for Kellanova, the investors are paying $2.2 for every $1 of sales.

Usana Health Sciences Inc. Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$854.5M
↓ 7.22%
Net Income
$42.0M
↓ 34.11%
Net Profit Margin
4.92%
↓ 2.01%

Usana Health Sciences Technicals Summary

Sell

Neutral

Buy

Usana Health Sciences is currently in a neutral trading position according to technical analysis indicators.

Usana Health Sciences Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Usana Health Sciences Inc. logo
6.35%
6.1%
-22.75%
-51.83%
-59.96%
Jbs Nv logo
21.83%
17.7%
17.7%
17.7%
17.7%
Kraft Heinz Company, The logo
-3.05%
-10.06%
-21.67%
-26.17%
-21.18%
Mccormick & Company, Incorporated logo
-2.14%
-15.43%
-11.6%
-17.59%
-32.24%
General Mills, Inc. logo
-1.55%
-20.08%
-32.11%
-37.07%
-24.25%
Kellanova logo
-0.41%
-4.13%
-1.31%
8.57%
12.08%

About Usana Health Sciences Inc.

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Organization
Usana Health Sciences
Employees
1700
CEO
Mr. Jim Brown
Industry
Consumer Non-Durables

Key Management of Usana Health Sciences Inc.

NameTitle
Mr. Jim Brown
CEO & President
Mr. G. Douglas Hekking
Chief Financial Officer
Mr. Walter Noot
Chief Operating Officer
Mr. P. Joshua Foukas J.D.
Chief Legal Officer, General Counsel & Corporate Secretary
Mr. Brent L. Neidig
Chief Commercial Officer
Dr. Myron W. Wentz Ph.D.
Founder & Chairman Emeritus
Dr. John Cuomo
Executive Director of Product Development & Technology
Peter Benedict
Chief Information Officer
Mr. Patrique Richards
Executive Director of Investor Relations & Business Development
Mr. David Mulham
Chief Sales Officer

Important FAQs about investing in USNA Stock from India :

What is Usana Health Sciences share price today?

Usana Health Sciences share price today is $31.74 as on . Usana Health Sciences share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Usana Health Sciences share?

Usana Health Sciences share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Usana Health Sciences stock price today i.e. is trending at $31.74, lower by 24.13% versus the 52 week high.

How to invest in Usana Health Sciences Stock (USNA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Usana Health Sciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Usana Health Sciences Shares that will get you 0.0473 shares as per Usana Health Sciences share price of $31.74 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Usana Health Sciences Stock (USNA) from India?

Indian investors can start investing in Usana Health Sciences (USNA) shares with as little as ₹88.167 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.67 in Usana Health Sciences stock (as per the Rupee-Dollar exchange rate as on August 29, 2025). Based on Usana Health Sciences share’s latest price of $31.74 as on August 30, 2025 at 1:29 am IST, you will get 0.3151 shares of Usana Health Sciences. Learn more about fractional shares .

What are the returns that Usana Health Sciences has given to Indian investors in the last 5 years?

Usana Health Sciences stock has given -59.96% share price returns and 20.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?